Aloe emodin is an anthraquinone derivative, which possesses the antiangiogenic effect on laser-induced choroidal neovascularization by inhibiting the HIF-1α/VEGF signaling pathway and has the potential to be developed for the prevention and treatment of diabetic retinopathy [35]. Here, HIF1A is linked to diabetic retinopathy.